Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Eton Pharmaceuticals, Inc. - Common Stock (NQ:ETON)

30.26 +0.30 (+1.00%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	543,172
Open	29.04
Bid (Size)	29.51 (100)
Ask (Size)	35.00 (100)
Prev. Close	29.96
Today's Range	28.00 - 30.88
52wk Range	13.09 - 32.31
Shares Outstanding	25,688,062
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Eton (ETON) Q1 2026 Earnings Call Transcript ↗

Today 13:21 EDT

Eton (ETON) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Eton Pharmaceuticals Q1 Earnings Call Highlights ↗

May 14, 2026

Eton Pharmaceuticals (NASDAQ:ETON) raised its 2026 revenue outlook after reporting record first-quarter product sales and highlighting early progress from two recent product launches, DESMODA and...

Via MarketBeat

Performance

YTD	+86.1%	+86.1%
1 Month	+11.6%	+11.6%
3 Month	+80.2%	+80.2%
6 Month	+79.3%	+79.3%
1 Year	+76.8%	+76.8%

More News

Eton Pharmaceuticals (NASDAQ:ETON) Soars on Q1 Beat, Raises Full-Year Guidance ↗

May 14, 2026

Via Chartmill

Eton Pharmaceuticals Reports First Quarter 2026 Financial Results

May 14, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals (NASDAQ:ETON) Posts Mixed Q4 2025 Results with Revenue Beat and EPS Miss ↗

March 19, 2026

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Eton Pharmaceuticals to Participate in Upcoming Investor Conferences

May 12, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

May 04, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution

May 01, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700

April 27, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces CFO Succession Plan

April 16, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharma (ETON) Earnings Call Transcript ↗

March 19, 2026

Via The Motley Fool

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

March 19, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing ↗

March 04, 2026

Via The Motley Fool

Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing ↗

March 04, 2026

Via The Motley Fool

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026

March 03, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution

March 02, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution

February 25, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th

February 20, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate

February 02, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharma (ETON) Q3 2025 Earnings Transcript ↗

November 09, 2025

Via The Motley Fool

ETON PHARMACEUTICALS INC (NASDAQ:ETON) Reports Q3 2025 Revenue Beat and EPS Miss ↗

November 06, 2025

Via Chartmill

Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results

November 06, 2025

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

October 23, 2025

From Eton Pharmaceuticals

Via GlobeNewswire

Eton (ETON) Q2 Revenue Jumps 108% ↗

August 07, 2025

Via The Motley Fool

Frequently Asked Questions

Is Eton Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Eton Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Eton Pharmaceuticals, Inc. - Common Stock trade on?

Eton Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock is ETON on the Nasdaq Stock Market

What is the current price of Eton Pharmaceuticals, Inc. - Common Stock?

The current price of Eton Pharmaceuticals, Inc. - Common Stock is 30.26

When was Eton Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Eton Pharmaceuticals, Inc. - Common Stock was at 05/15/26 04:00 PM ET

What is the market capitalization of Eton Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Eton Pharmaceuticals, Inc. - Common Stock is 777.32M

How many shares of Eton Pharmaceuticals, Inc. - Common Stock are outstanding?

Eton Pharmaceuticals, Inc. - Common Stock has 777M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.